DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 91 filers reported holding DYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,208,787 | -20.4% | 692,945 | 0.0% | 0.95% | -12.1% |
| Q2 2023 | $7,795,631 | -2.3% | 692,945 | 0.0% | 1.08% | -5.6% |
| Q1 2023 | $7,982,726 | +57.6% | 692,945 | +31.9% | 1.15% | +4.9% |
| Q1 2022 | $5,064,000 | -27.0% | 525,284 | -10.0% | 1.10% | -18.9% |
| Q4 2021 | $6,940,000 | -26.8% | 583,649 | 0.0% | 1.35% | -42.1% |
| Q3 2021 | $9,478,000 | -22.8% | 583,649 | 0.0% | 2.33% | -8.2% |
| Q2 2021 | $12,280,000 | +35.5% | 583,649 | 0.0% | 2.54% | -25.5% |
| Q1 2021 | $9,064,000 | -10.4% | 583,649 | +21.2% | 3.41% | -2.6% |
| Q4 2020 | $10,112,000 | – | 481,538 | – | 3.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
| Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
| Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
| Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
| HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
| Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
| COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
| RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |